Publications by authors named "Scott Greenfeder"

Claim this Profile
A
A Review and Comparative Case Study Analysis of Real-World Evidence in European Regulatory and Health Technology Assessment Decision Making for Oncology Medicines.
Jihong Zong, Adina Rojubally, Xiaoyun Pan, Birgit Wolf, Scott Greenfeder

Value Health· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk.
Ian Graham, Chuck Shear, Pieter De Graeff, Caroline Boulton, Alberico L Catapano, Scott Greenfeder

Eur Heart J Cardiovasc Pharmacother· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuromodulation mediated by the tachykinin NK3-receptor agonist [MePhe7]-neurokinin B in the isolated perfused lung of nonsensitized nonchallenged and ovalbumin-sensitized and -challenged guinea pig.
Michel R Corboz, Maria A Rivelli, Xiomara Fernandez, Scott Greenfeder

Exp Lung Res· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAR studies of C2 ethers of 2H-pyrano[2,3-d]pyrimidine-2,4,7(1H,3H)-triones as nicotinic acid receptor (NAR) agonist.
Xianhai Huang, Jing Su, Ashwin U Rao, Haiqun Tang, Wei Zhou, Scott Greenfeder

Bioorg Med Chem Lett· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia.
Anandan Palani, Ashwin U Rao, Xiao Chen, Xianhai Huang, Jing Su, Scott Greenfeder

ACS Med Chem Lett· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice.
Michaela C Stanton, Shu-Cheng Chen, James V Jackson, Alberto Rojas-Triana, David Kinsley, Scott Greenfeder

J Inflamm (Lond)· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a potent nicotinic Acid receptor agonist for the treatment of dyslipidemia.
Jun Qin, Ashwin Rao, Xiao Chen, Xiaohong Zhu, Zhidan Liu, Scott Greenfeder

ACS Med Chem Lett· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging strategies and agents to lower cardiovascular risk by increasing high density lipoprotein cholesterol levels.
Scott Greenfeder

Curr Med Chem· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cloning and characterization of the hamster and guinea pig nicotinic acid receptors.
April Smith Torhan, Boonlert Cheewatrakoolpong, Lia Kwee, Scott Greenfeder

J Lipid Res· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of splice variants of the human P2X7 ATP channel.
Boonlert Cheewatrakoolpong, Helen Gilchrest, John C Anthes, Scott Greenfeder

Biochem Biophys Res Commun· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cloning and pharmacological characterization of mouse TRPV1.
Craig C Correll, P Tara Phelps, John C Anthes, Shelby Umland, Scott Greenfeder

Neurosci Lett· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human cord blood-derived mast cells synthesize and release I-309 in response to IgE.
Helen Gilchrest, Boonlert Cheewatrakoolpong, Motasim Billah, Robert W Egan, John C Anthes, Scott Greenfeder

Life Sci· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New asthma targets: recent clinical and preclinical advances.
Scott Greenfeder, John C Anthes

Curr Opin Chem Biol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor.
John C Anthes, Helen Gilchrest, Christian Richard, Stephen Eckel, Dave Hesk, Scott Greenfeder

Eur J Pharmacol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
John C Anthes, Richard W Chapman, Christian Richard, Stephen Eckel, Michel Corboz, Scott Greenfeder

Eur J Pharmacol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IL-5 receptor on human bronchus selectively primes for hyperresponsiveness.
Charles A Rizzo, Richard Yang, Scott Greenfeder, Robert W Egan, Romain A Pauwels

J Allergy Clin Immunol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis